Europe Pen Needles Market (2024-2029)
The Europe Pen Needles Market was valued at $19.87 Million in 2024 and projected to reach to $26.92 Million by 2029, representing a compound annual growth rate of 5.2%. Europe's pen needles market demonstrates robust growth potential driven by increasing diabetes prevalence, aging populations, and rising adoption of injectable therapies across the continent.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe Pen Needles Market Trends and Insights
- GCC Countries demonstrates a compound annual growth rate (CAGR) of 5.2% throughout the forecast period, reflecting increasing adoption of injectable diabetes management solutions across the region.
- The growth trajectory in GCC Countries is driven by rising diabetes prevalence, improved healthcare infrastructure, and growing patient awareness of advanced injection technologies. GCC Countries' pen needles market is characterized by expanding demand from both healthcare providers and patients seeking convenient, safe, and effective injection devices.
- The market in GCC Countries benefits from strong economic conditions and substantial healthcare investments that support the adoption of modern medical devices.
- Between 2024 and 2029, GCC Countries is expected to witness accelerated market penetration as pharmaceutical companies and medical device manufacturers strengthen their regional presence and distribution networks..
Key Market Statistics
- CAGR (2024-2029) 5.2% CAGR
- Market Size, 2024 ~USD 19.87 Million
- Forecast, 2029 ~USD 26.92 Million
- Geography Europe
Europe Pen Needles Market Overview
Market Leadership :
Europe commands a significant share of the global pen needles market, with major markets including Germany (€165.58M), UK (€166.32M), and France (€127.52M), establishing the region as a key revenue driver for injectable diabetes management solutions.
Steady Regional Growth :
The European pen needles market is projected to grow at a CAGR of 5.2% through 2029, demonstrating consistent adoption of advanced injection devices across healthcare systems and patient populations seeking improved diabetes management.
Diverse Market Composition :
Europe's pen needles market comprises both established Western European economies and emerging markets in Central and Eastern Europe, with Rest of Europe contributing €535.1M, reflecting varied healthcare infrastructure and penetration levels.
Healthcare Integration :
Strong reimbursement policies, established diabetes care protocols, and high healthcare spending across European nations support sustained demand for premium pen needle products and innovative delivery systems.
Europe Pen Needles Market Dynamics
- The region benefits from well-established healthcare infrastructure, favorable reimbursement frameworks, and strong patient awareness regarding diabetes management.
- Major Western European markets including Germany, UK, and France lead in market value, while emerging Eastern European markets present expansion opportunities.
- Healthcare providers and pharmaceutical companies continue investing in patient education and device innovation to enhance treatment compliance and outcomes. The forecast period through 2029 anticipates sustained market expansion as European healthcare systems prioritize diabetes care quality and accessibility.
- Technological advancements in pen needle design, coupled with growing preference for self-administered injectable therapies, will drive market penetration.
- Regulatory support and integration of digital health solutions further strengthen Europe's position as a mature, innovation-driven market for pen needle products..
Related Ecosystem
Drug Delivery Devices
- Disposable Autoinjectors
- Reusable Autoinjectors
- Insulin Pumps
- Pen Injectors
- Transdermal Patches
- Novo nordisk a/s
- Becton, Dickinson and Company
- Terumo Corporation
- Medtronic plc
- Nipro Corporation
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- GCC Countries pen needles market valued at $19.87 million in 2024, growing to $26.92 million by 2029 at 5.2% CAGR
- Rising diabetes prevalence in GCC Countries drives demand for reliable, user-friendly injection devices
- GCC Countries benefits from robust healthcare infrastructure and strong economic capacity for medical device adoption
- Market expansion in GCC Countries supported by increased pharmaceutical company investments and improved distribution channels
Pen Needles Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | SAFETY PEN NEEDLES (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 9.2% from 2024 to 2029 |
| Largest Segment | STANDARD PEN NEEDLES (Type) |
| Market Size Base Year (Billions) | ~USD 1.82 (2024) |
| Revenue Forecast (Billions) | ~USD 3.08 (2029) |
| Segments Covered | Type, Length, Application, Mode Of Purchase, Care Setting |
Europe Pen Needles Market Report Segmentation
5 segment dimensions are covered across the global market.
By Type
- Safety Pen Needles
- Standard Pen Needles
By Length
- 10Mm
- 12Mm
- 4Mm
- 5Mm
- 6Mm
- 8Mm
By Application
- Glp-1 Therapy
- Growth Hormone Therapy
- Insulin Therapy
- Osteoporosis
- Other Applications
By Mode Of Purchase
- Online Purchase
- Otc Purchase
- Other Modes Of Purchase
- Prescription-Based Purchase
By Care Setting
- Home Care Settings
- Hospitals & Clinics
- Hospitals And Clinics
- Other End Users
EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| GLP-1 THERAPY | 33.3 | 34.3 | 36.3 | 38.8 | 41.6 | 48.3 | 52.3 | 56.9 | 7.8 |
| GROWTH HORMONE THERAPY | 9.2 | 9.1 | 9.2 | 9.5 | 9.8 | 10.5 | 11 | 11.5 | 3.7 |
| INSULIN THERAPY | 447.8 | 465.9 | 496.9 | 536.7 | 581 | 687.3 | 751.3 | 824.1 | 8.8 |
| OSTEOPOROSIS | 26.3 | 27 | 28.4 | 30.3 | 32.3 | 37.2 | 40.1 | 43.4 | 7.3 |
| OTHER APPLICATIONS | 45.2 | 45.7 | 47.3 | 49.6 | 52.1 | 58.1 | 61.6 | 65.6 | 5.6 |
| TOTAL | 561.8 | 582 | 618.1 | 664.8 | 716.9 | 841.5 | 916.3 | 1001.5 | 8.4 |
REST OF EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| GLP-1 THERAPY | 8.72 | 9 | 9.51 | 10.18 | 10.93 | 12.7 | 13.76 | 14.96 | 7.8 |
| GROWTH HORMONE THERAPY | 1.97 | 1.96 | 1.99 | 2.05 | 2.11 | 2.27 | 2.37 | 2.48 | 3.7 |
| INSULIN THERAPY | 129.19 | 134.46 | 143.48 | 155.01 | 167.88 | 198.69 | 217.22 | 238.31 | 8.8 |
| OSTEOPOROSIS | 6.56 | 6.74 | 7.09 | 7.56 | 8.08 | 9.3 | 10.04 | 10.86 | 7.4 |
| OTHER APPLICATIONS | 12.16 | 12.29 | 12.74 | 13.36 | 14.05 | 15.68 | 16.65 | 17.74 | 5.7 |
| TOTAL | 158.61 | 164.45 | 174.81 | 188.16 | 203.04 | 238.64 | 260.03 | 284.34 | 8.4 |
Target Audience
- Medical Device Manufacturers : Manufacturers need comprehensive European market data to develop region-specific product strategies, identify growth opportunities in high-value markets, and optimize distribution networks across diverse healthcare systems.
- Pharmaceutical Companies : Pharma firms require detailed market intelligence to align injectable diabetes therapy portfolios with pen needle adoption trends, support sales force planning, and enhance patient access programs across Europe.
- Healthcare Investors & PE Firms : Investment professionals need accurate market sizing, growth projections, and competitive analysis to evaluate acquisition targets, assess portfolio company performance, and identify emerging investment opportunities in European diabetes care.
- Healthcare Consultants & Advisors : Consultants require granular European market data to support client strategy development, competitive benchmarking, market entry planning, and business case development for healthcare organizations and medical device companies.
- Distributors & Healthcare Providers : Distributors and providers need market insights to forecast demand, optimize inventory management, negotiate supplier contracts, and align procurement strategies with regional market trends and patient needs.
Key Companies in the Europe Pen Needles Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Injectable and infusion-based delivery in LTAC hospitals,Oral drug administration in inpatient rehabilitation facilities,Contract rehabilitation and outpatient-related drug administration support, |
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automated manufacturing and assembly systems,Lifecycle services and digital/connected factory solutions,Contract manufacturing and value-added integration, |
| ALLERGAN PLC | Ireland | Private Company | Medical Aesthetics & Dermatology,Eye Care,Neuroscience & CNS, |
| CONSORT MEDICAL | United Kingdom | Private Company | Inhalation delivery devices,Injectable and autoinjector devices,Nasal and other specialty devices, |
| HENRY SCHEIN | United States | Public Company | Global Distribution & Value-Added Services,Global Specialty Products,Global Technology, |
| EMBECTA CORP. | United States | Public Company | Pen needles,Syringes,Safety injection devices, |
| NOVO NORDISK A/S | Denmark | Public Company | GLP-1 for Diabetes (injectable and oral),Obesity Care (GLP-1, including Wegovy pill),Insulin and Smart Pens (NovoPen 6, Echo Plus, needles), |
| YPSOMED | Switzerland | Public Company | Pen injectors,Auto-injectors,Wearable injectors and patch pumps, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| NIPRO | Japan | Public Company | Dialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceutical-related (generics, kits, CDMO for injectables and oral drugs), |
| ARKRAY, INC. | Japan | Private Company | Diabetes testing & blood glucose monitoring,Urinalysis,Immunodiagnostics, |
| HTL-STREFA | Poland | Private Company | Safety lancets for professional capillary sampling,Personal lancets for home blood glucose monitoring,Pen needles for diabetes therapy, |
| BERPU MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | Regular insulin pen needles,Safety insulin pen needles and pens,Hypodermic and hypo-dermal needles, |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates with 64,200 employees. The company provides healthcare services and related solutions across the United States.
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ALLERGAN PLC
Allergan PLC is an Ireland-based private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and medical aesthetics sectors.
CONSORT MEDICAL
Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees. The company provides medical device and pharmaceutical delivery solutions.
HENRY SCHEIN
Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to medical, dental, and veterinary professionals.
EMBECTA CORP.
Embecta Corp. is a United States-based public company founded in 1924 with 1,850 employees. The company manufactures and distributes diabetes care and medical devices.
NOVO NORDISK A/S
Novo Nordisk A/S is a Denmark-based public company founded in 1923 with 67,900 employees. The company is a global pharmaceutical company specializing in diabetes, obesity, and other chronic diseases.
YPSOMED
Ypsomed is a Switzerland-based public company founded in 1984 with 2,025 employees. The company develops and manufactures injection and infusion systems for diabetes and other therapeutic areas.
TERUMO CORPORATION
Terumo Corporation is a Japan-based public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices, blood products, and pharmaceutical solutions globally.
NIPRO
Nipro is a Japan-based public company founded in 1947 with 38,593 employees. The company manufactures and supplies medical devices, pharmaceuticals, and healthcare products worldwide.
ARKRAY, INC.
Arkray, Inc. is a Japan-based private company founded in 1960 with 566 employees. The company manufactures diagnostic and medical devices for healthcare applications.
HTL-STREFA
HTL-Strefa is a Poland-based private company founded in 2000. The company manufactures medical devices and related healthcare products.
BERPU MEDICAL TECHNOLOGY CO., LTD.
Berpu Medical Technology Co., Ltd. is a China-based private company founded in 2000. The company manufactures medical devices and related healthcare solutions.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 165.58 Million |
| UK | USD 166.32 Million |
| France | USD 127.52 Million |
| Italy | USD 75.76 Million |
| Spain | USD 55.01 Million |
| Rest of Europe | USD 535.1 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Segmentation : Gain detailed insights into Europe's largest markets (Germany, UK, France) and emerging opportunities in Rest of Europe, enabling targeted market entry and expansion strategies specific to regional healthcare dynamics.
- Competitive Landscape Analysis : Understand market positioning, competitive dynamics, and key player strategies across diverse European healthcare systems, supporting informed business development and partnership decisions.
- Growth Forecasting : Access accurate 5-year projections (2024-2029) with 5.2% CAGR data to support investment decisions, resource allocation, and long-term strategic planning in the European pen needles sector.
- Regulatory & Reimbursement Insights : Leverage region-specific analysis of healthcare policies, reimbursement frameworks, and regulatory requirements that influence market adoption and pricing strategies across European nations.
- Patient & Provider Trends : Identify emerging trends in diabetes management preferences, device adoption patterns, and healthcare provider requirements to align product development and marketing initiatives with European market demands.
Frequently asked questions
What is the current market size of pen needles in GCC Countries?
The pen needles market in GCC Countries was valued at $19.87 million in 2024 and is projected to reach $26.92 million by 2029.
What is the expected growth rate for pen needles in GCC Countries?
GCC Countries' pen needles market is expected to grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2029.
What factors are driving growth in the GCC Countries pen needles market?
Growth in GCC Countries is driven by rising diabetes prevalence, improved healthcare infrastructure, increased patient awareness, and strong economic conditions supporting medical device adoption.
How much will the pen needles market in GCC Countries grow by 2029?
The pen needles market in GCC Countries is expected to grow by approximately $7.05 million, from $19.87 million in 2024 to $26.92 million in 2029.
Why is GCC Countries an important market for pen needles?
GCC Countries represents a significant market due to high diabetes prevalence, strong healthcare spending, robust economic conditions, and increasing adoption of advanced injection technologies in the region.
RESEARCH METHODOLOGY
This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the pen needles market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the pen needles market. Primary sources from the demand side included hospitals, clinics, researchers, lab technicians, purchase managers etc, and stakeholders in corporate & government bodies.
A breakdown of the primary respondents for pen needles market (supply side) market is provided below:
Note 1: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 3: Other primaries include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size for pen needles market was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for pen needles market was calculated using data from three distinct sources, as will be discussed below:
Data Triangulation
The entire market was split up into five segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.
Approach to derive the market size and estimate market growth.
Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of pen needles. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
A pen needle is a hollow needle entrenched in a plastic hub and attached to injectable pens. Pen needles are available in a wide range of lengths and diameters and can be used by healthcare professionals and patients to deliver injectable medications into the patient’s body. Pen needles are electro-polished for smooth, thin, and fine-point tips and provide comfort and ease in penetration; they serve as an alternative drug delivery technique to the traditional method of injecting drugs.
Stakeholders
- Manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Original equipment manufacturing companies
- Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Healthcare service providers
- Teaching hospitals and academic medical centers
- Health insurance players
- Government bodies/municipal corporations
- Regulatory bodies
- Business research and consulting service providers
- Authorities framing reimbursement policies for pen needles
- Venture capitalists
- Market research and consulting firms
Report Objectives
- To define, describe, and forecast the pen needles market based on type, length, application, mode of purchase, setting and region.
- To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall pen needles market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the pen needles market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa and GCC Countries
- To profile the key players and comprehensively analyze their market shares and core competencies in the pen needles market
- To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the pen needles market
- To benchmark players within the pen needles market using the Company Evaluation Quadrant framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings.
Get the Full Pen Needles Market Report
Full forecast, segment splits, and company analysis for all Pen Needles Market.
- Canada Pen Needles Market
- US Pen Needles Market
- Germany Pen Needles Market
- UK Pen Needles Market
- France Pen Needles Market
- Italy Pen Needles Market
- Spain Pen Needles Market
- Japan Pen Needles Market
- China Pen Needles Market
- India Pen Needles Market
- South Korea Pen Needles Market
- Brazil Pen Needles Market
- Mexico Pen Needles Market
- Argentina Pen Needles Market
- GCC Countries Pen Needles Market
- Rest Of Europe Pen Needles Market
- Rest Of Asia Pacific Pen Needles Market
- Southeast Asia Pen Needles Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
